{"schema_version":"secwatch.filing_event.v1","accession":"0001651308-24-000123","form_type":"8-K","ticker":"ONC","cik":"0001651308","company_name":"BeOne Medicines Ltd.","filed_at":"2024-09-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.967169+00:00","generated_at":"2026-05-31T00:45:25.290862+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"low","headline":"BeiGene updates risk factors due to SEC comment letter on China operations","bullets":["SEC staff requested restoration of certain risk factor language related to China operations from 2022 10-K.","Updated risk factors filed as Exhibit 99.1, restating those in 2023 10-K and subsequent 10-Qs.","Specific content of updated risk factors not detailed in available filing text."],"urls":{"canonical":"https://secwatch.observer/filing/0001651308-24-000123","json":"https://secwatch.observer/filing/0001651308-24-000123.json","markdown":"https://secwatch.observer/filing/0001651308-24-000123.md","text":"https://secwatch.observer/filing/0001651308-24-000123.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000123/0001651308-24-000123-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000123/bgne-20240930.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T00:45:25.290862+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}